Showing results (231-240 of 908) with videos related to

Sort By:
Pageof 91
Circulation. Heart Failure|April 30, 2013
Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF studyHenry Krum, Harry Shi, Bertram Pitt, et al.
Circulation. Cardiovascular Quality and Outcomes|January 12, 2017
Characterization of Mineralocorticoid Receptor Antagonist Therapy Initiation in High-Risk Patients With Heart FailureLauren B Cooper, Bradley G Hammill, Eric D Peterson, et al.
European Journal of Heart Failure|August 9, 2012
Statin therapy and clinical outcomes in myocardial infarction patients complicated by acute heart failure: insights from the EPHESUS trialDaniela Dobre, Patrick Rossignol, Jan Murin, et al.
European Heart Journal|June 17, 2022
Non-steroidal mineralocorticoid receptor antagonists in cardiorenal diseaseArjun K Pandey, Deepak L Bhatt, Francesco Cosentino, et al.
European Heart Journal|September 21, 2006
Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT TrialUchechukwu K Sampson, Marc A Pfeffer, John J V McMurray, et al.
Circulation|May 7, 2003
Left ventricular remodeling and ventricular arrhythmias after myocardial infarctionMartin St John Sutton, Douglas Lee, Jean Lucien Rouleau, et al.
Clinical Trials (London, England)|August 24, 2012
Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical studyLihui Zhao, Lu Tian, Hajime Uno, et al.
American Heart Journal|March 30, 2002
Expanding the outcomes in clinical trials of heart failure: the quality of life and economic components of EPHESUS (EPlerenone's neuroHormonal Efficacy and SUrvival Study)John A Spertus, Joseph Tooley, Phil Jones, et al.
American Heart Journal|November 11, 2019
Income level and inequality as complement to geographical differences in cardiovascular trialsJoão Pedro Ferreira, Patrick Rossignol, Pooja Dewan, et al.
American Journal of Hypertension|July 20, 2023
Efficacy and Safety of Ocedurenone: Subgroup Analysis of the BLOCK-CKD StudyGeorge L Bakris, Y Fred Yang, James M McCabe, et al.
Pageof 91